WO2023285580 - TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
National phase entry:
Publication Number
WO/2023/285580
Publication Date
19.01.2023
International Application No.
PCT/EP2022/069704
International Filing Date
14.07.2022
Title **
[English]
TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID
[French]
COMPRIMÉ COMPRENANT UN SEL D'ACIDE N-(8-(2-HYDROXYBENZOYL)AMINO) CAPRYLIQUE
Applicants **
NOVO NORDISK A/S
Novo Allé
2880 Bagsværd, DK
Inventors
VILHELMSEN, Thomas, Kvistgaard
Novo Allé
2880 Bagsværd, DK
CHRISTENSEN, Isabell, Vargas
Novo Allé
2880 Bagsværd, DK
Priority Data
21185861.8
15.07.2021
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1260 | |
| EPO | Filing, Examination | 5044 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 10183 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to a tablet comprising a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid. The invention further relates to processes for the preparation such a tablet, and its use in medicine.[French]
L'invention concerne un comprimé comprenant un sel d'acide N-(8-(2-hydroxybenzoyl)amino) caprylique. L'invention concerne en outre des procédés de préparation d'un tel comprimé et son utilisation en médecine.